MENLO PARK, Calif., March 21, 2017 /PRNewswire/ -- BioPharmX Corporation (NYSE MKT: BPMX), a specialty pharmaceutical company developing products for the dermatology market, has been invited to present at Oppenheimer's 27th Annual Healthcare Conference in New York.

BioPharmX co-founder and President Anja Krammer will provide an overview of the company at the conference tomorrow at 1:00 p.m. EDT in the Consulate conference room of the Westin New York Grand Central. BioPharmX is one of about 100 companies selected to meet with individual investors and small groups. 

The live webcast will be available at https://www.veracast.com/webcasts/opco/healthcare2017/58208200176.cfm 

The annual Oppenheimer Healthcare Conference, hosted by Oppenheimer & Co. March 21 and 22, is one of the most important investor conferences in the healthcare sector, providing the first glimpse into the issues and companies that will be prevalent in 2017.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/biopharmx-invited-to-present-at-27th-annual-oppenheimer-healthcare-conference-300426695.html

SOURCE BioPharmX Corporation

Copyright 2017 PR Newswire

Grafico Azioni BioPharmX (AMEX:BPMX)
Storico
Da Giu 2024 a Lug 2024 Clicca qui per i Grafici di BioPharmX
Grafico Azioni BioPharmX (AMEX:BPMX)
Storico
Da Lug 2023 a Lug 2024 Clicca qui per i Grafici di BioPharmX